(*) EU Approval Date: 2020. 02.18.
(*) JP Approval Date: 2019. 03.
(*) USA Approval Date: 2019. 05.06.
>Tafamidis/Tafamidis Meglumine
Familial Amyloid CardioMyopathy
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 12
Patent>UpDate: 2020. 02.18.
TradeMarks
TradeMarks Web-Site
Wild-Type or Hereditary>